Quantcast

Latest Stem cell treatments Stories

2014-04-08 16:22:59

BEVERLY HILLS, Calif., April 8, 2014 /PRNewswire/ -- Life Stem Genetics, Inc. (LIFS), an emerging company in the advancement of adult stem cell therapies, today announced the appointments of Dr. Roberto Fernandez Vina, Dr. Ranbir Singh Gill, and Dr. Praveen Gill to its Medical Advisory Board. Dr. Roberto Fernandez Vina Born and educated in Argentina, Dr. Roberto Fernandez Vina, MD Cardiology, is a pioneer in the development of multiple adult stem cell therapies, protocols, and...

2014-04-07 08:32:26

Will Also Present Update on Ongoing Phase II Trial ROCKVILLE, Md., April 7, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, PhD, MD, principal investigator of Neuralstem's NSI-566 stem cell trial in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) will present Phase I data at the Keystone Symposia, "Engineering Cell Fate and Function," in Olympic Valley, California, on April 9(th...

2014-04-04 23:41:39

Dr. Jeffrey Adler of Adler Footcare New York will discuss stem cell replacement therapy, a new treatment option available to treat painful foot problems, on NewsTalkRadio 77 WABC in New York City on April 5. New York, New York (PRWEB) April 03, 2014 Dr. Jeffrey Adler, New York podiatrist and Owner/Medical Director of Adler Footcare New York, will be interviewed by radio personality Laura Smith and taking live calls on New York talk show 77 WABC about the use of stem cells to treat...

2014-04-02 11:30:25

Animal study points to promise of gene therapy for treating spinal cord injury Delivering a single injection of a scar-busting gene therapy to the spinal cord of rats following injury promotes the survival of nerve cells and improves hind limb function within weeks, according to a study published April 2 in The Journal of Neuroscience. The findings suggest that, with more confirming research in animals and humans, gene therapy may hold the potential to one day treat people with spinal cord...

2014-04-01 15:21:02

Researchers report they can generate human motor neurons from stem cells much more quickly and efficiently than previous methods allowed. The finding, described in Nature Communications, will aid efforts to model human motor neuron development, and to understand and treat spinal cord injuries and motor neuron diseases such as amyotrophic lateral sclerosis (ALS). The new method involves adding critical signaling molecules to precursor cells a few days earlier than previous methods...

2014-04-01 08:30:20

Safety, Efficacy, Patient Satisfaction Drive StemGenex' Efforts toward Best-in-Class Stem Cell Treatment LA JOLLA, Calif., April 1, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today reinforced their commitment to attaining the highest treatment standards in the U.S. StemGenex believes by focusing on three key areas of treatment, patients will continue...

2014-03-31 08:30:29

Company Generates Record Cash Flow from Operations of $500,000, up 509% LAS VEGAS, March 31, 2014 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the year ended December 31, 2013. Full Year Ended December 31, 2013 Highlights -- Recurring revenues increased approximately 14% to $3.05 million for the year ended 2013, which represents 51% of total revenue. --...

2014-03-28 08:27:33

First Study To Validate Cell Survival and Functionality in Brain, Improvement Dose Dependent ROCKVILLE, Md., March 28, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that a study published in the peer-reviewed journal, PLOS ONE, showed that ischemic-stroke rats transplanted with Neuralstem's NSI-566 stem cells in the brain experienced functional improvements. Furthermore, the grafts both survived and differentiated into neurons. These findings further validate the...

2014-03-26 23:30:02

RSCI’s one-day treatment program in Florida, USA, is priced to bring stem cell treatment benefits to the greatest possible number of SCI patients. Dallas, TX (PRWEB) March 26, 2014 The Repair Stem Cells Institute (RSCI – http://www.repairstemcells.org) announces its new “Double Benefits for SCI” stem cell treatment program specifically to benefit sufferers of Spinal Cord Injuries (SCI). The Regenerative Center, headed by Dr. Melvin M. Propis, a well-known practitioner of stem...

2014-03-26 23:03:19

First use will be in NIH clinical research study and protocol to study the use of bone marrow stem cells during cardiac surgery to treat heart muscle dysfunction associated with ischemic heart disease or damage from heart attack. Fayetteville, Arkansas (PRWEB) March 26, 2014 CardioWise, Inc. and the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) have signed a Beta Site Agreement to serve as a clinical test site for CardioWise Multiparametric Strain...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related